Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 2
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Toxicity Assessment of [177Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes.
Hernández-Jiménez T, Cruz-Nova P, Ancira-Cortez A, Gibbens-Bandala B, Lara-Almazán N, Ocampo-García B, Santos-Cuevas C, Morales-Avila E, Ferro-Flores G. Hernández-Jiménez T, et al. Among authors: cruz nova p. Nanomaterials (Basel). 2022 Nov 25;12(23):4181. doi: 10.3390/nano12234181. Nanomaterials (Basel). 2022. PMID: 36500804 Free PMC article.
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.
Ocampo-García B, Cruz-Nova P, Jiménez-Mancilla N, Luna-Gutiérrez M, Oros-Pantoja R, Lara-Almazán N, Pérez-Velasco D, Santos-Cuevas C, Ferro-Flores G. Ocampo-García B, et al. Among authors: cruz nova p. Int J Mol Sci. 2023 Nov 21;24(23):16553. doi: 10.3390/ijms242316553. Int J Mol Sci. 2023. PMID: 38068876 Free PMC article.
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.
Ferro-Flores G, Ocampo-García B, Cruz-Nova P, Luna-Gutiérrez M, Bravo-Villegas G, Azorín-Vega E, Jiménez-Mancilla N, Michel-Sánchez E, García-Pérez O, Lara-Almazán N, Santos-Cuevas C. Ferro-Flores G, et al. Among authors: cruz nova p. Pharmaceutics. 2023 Nov 23;15(12):2662. doi: 10.3390/pharmaceutics15122662. Pharmaceutics. 2023. PMID: 38140003 Free PMC article.
Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.
Luna-Gutiérrez M, Cruz-Nova P, Jiménez-Mancilla N, Oros-Pantoja R, Lara-Almazán N, Santos-Cuevas C, Azorín-Vega E, Ocampo-García B, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: cruz nova p. Int J Mol Sci. 2023 Aug 3;24(15):12382. doi: 10.3390/ijms241512382. Int J Mol Sci. 2023. PMID: 37569758 Free PMC article.
Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging.
Trujillo-Benítez D, Luna-Gutiérrez M, Ferro-Flores G, Ocampo-García B, Santos-Cuevas C, Bravo-Villegas G, Morales-Ávila E, Cruz-Nova P, Díaz-Nieto L, García-Quiroz J, Azorín-Vega E, Rosato A, Meléndez-Alafort L. Trujillo-Benítez D, et al. Among authors: cruz nova p. Molecules. 2022 Jan 1;27(1):264. doi: 10.3390/molecules27010264. Molecules. 2022. PMID: 35011496 Free PMC article.
131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B-PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer-Biological Characterization, Biokinetics and Dosimetry.
Cruz-Nova P, Ocampo-García B, Carrión-Estrada DA, Briseño-Diaz P, Ferro-Flores G, Jiménez-Mancilla N, Correa-Basurto J, Bello M, Vega-Loyo L, Thompson-Bonilla MDR, Hernández-Rivas R, Vargas M. Cruz-Nova P, et al. Molecules. 2022 Aug 25;27(17):5446. doi: 10.3390/molecules27175446. Molecules. 2022. PMID: 36080216 Free PMC article.
12 results